CDEK
← All organizations

Immune Pharmaceuticals

For profitWebsite ↗
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 1, 2015

Last known activity

Feb 1, 2016

Acquired by United General Ltd on Mar 29, 2021

Timeline

2010s

  1. Jun 1, 2010

    Immune Pharmaceuticals— Founded

  2. Nov 8, 2012

    EpiCept Corporation— Acquired

  3. Feb 19, 2019

    Immune Pharmaceuticals— Defunct

2020s

  1. Mar 29, 2021

    United General Ltd— Acquired By

Drugs by trial phase (8 distinct, 9 trials)

Phase 4 (0 own, 2 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (2)

Details

Founded
New York, NY, US Jun 1, 2010
Last known activity
Feb 1, 2016